Bristol-Myers Squibb Company (BMY) |
|
63.97 -1.66 (-2.53%)
|
02-24 16:00 |
|
Open: |
64.08 |
Pre. Close: |
65.63 |
|
High:
|
65.06 |
Low:
|
63.69 |
|
Volume:
|
11,457,122 |
Market Cap:
|
149958M |
|
|
|
|
Bristol-Myers Squibb Co is engaged in discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceuticals products. The company operates in one segment that is Biopharmaceuticals. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
65.244 - 65.606 |
65.606 - 65.899 |
|
Low:
|
62.567 - 63.081 |
63.081 - 63.499 |
|
Close:
|
63.215 - 63.976 |
63.976 - 64.595 |
|
Technical analysis |
as of: 2020-02-24 4:41:38 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 77.22  One year: 79.82 |
| Support: |
Support1: 62.51 Support2: 52.01 |
| Resistance: |
Resistance1: 66.11 Resistance2: 68.34 |
| Pivot: |
65.78  |
| Moving Average: |
MA(5): 65.31 MA(20): 65.31
MA(100): 60.18 MA(250): 52.46 |
| MACD: |
MACD(12,26): 0.23 Signal(9): 0.49 |
| Stochastic oscillator: |
%K(14,3): 42.88 %D(3): 52.94 |
| RSI: |
RSI(14): 42.59 |
| 52-week: |
High: 68.34 Low: 42.48 Change(%): 27.5 |
| Average Vol(K): |
3-Month: 1455285 10-Days: 1037977 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.BMY has closed above bottom band by 8.1%. Bollinger Bands are 13.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 07 Feb 2020 21:24:51 +0000
After Hours Most Active for Feb 7, 2020 : ABEV, AUY, MSFT, ZNGA, BMY, INTC, KGC, VALE, MRK, QQQ, FB, MU
Sun, 23 Feb 2020 14:32:00 +0000
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Sun, 23 Feb 2020 12:31:00 +0000
3 Cancer Treatment Stocks to Buy Right Now
Wed, 19 Feb 2020 19:58:00 +0000
FDA Approved 1,014 Generic Drugs in 2019
Wed, 19 Feb 2020 14:51:39 +0000
Jim Simons: The Investing Guru Bets on These 3 Healthcare Stocks
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: New York Stock Exchange |
| Sector: Healthcare |
| Industry: Drug Manufacturers - Major |
| Shares Out. (M) |
2340.00 |
| Shares Float (M) |
1630.00 |
|
% Held by Insiders
|
0.10 |
|
% Held by Institutions
|
75.90 |
|
Shares Short (K)
|
67980 |
|
Shares Short P. Month (K)
|
|
Stock Financials |
|
EPS
|
2.010 |
|
Book Value (p.s.)
|
10.830 |
|
PEG Ratio
|
0.77 |
|
Profit Margin
|
13.15 |
|
Operating Margin
|
27.16 |
|
Return on Assets (ttm)
|
|
|
Return on Equity (ttm)
|
21.7 |
|
Qtrly Rev. Growth
|
33.0 |
|
Gross Profit (p.s.)
|
8.090 |
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
3.295 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
|
|
Levered Free Cash Flow (M)
|
|
Stock Valuations |
|
P/E
|
31.83 |
|
P/E Growth Ratio
|
-0.03 |
|
P/BV
|
5.91 |
|
P/S
|
4.17 |
|
P/CF
|
|
Dividends & Splits |
|
Dividend
|
1.680 |
|
Dividend Yield
|
0.03 |
|
Dividend Pay Date
|
2020-02-02 |
|
Ex-Dividend Date
|
2020-01-01 |
|
Forward Dividend
|
1.800 |
|
Last Split Date
|
|
|
Last Split Ratio
|
-2.1 |
|
7 Binary Options
|
|
Your Ad Here
|
|
